WebJul 16, 2024 · Acquired Organization: GC Cell GC Cell specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007. Acquiring Organization: Green Cross Lab Cell Green Cross Lab Cell Corporation develops cell therapy products. Announced Date Jul 16, 2024 Acquisition Type Merger WebGC LabCell, which came out of a merger between the cell therapy division of GC Biopharma and the cord blood storage division of GC Labs, focuses on its strategic tasks of researching and developing Natural Killer(NK) cell-based immunotherapy agents …
GREEN CROSS CELL CORPORATION : Shareholders Board …
WebJun 26, 2024 · GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem … WebApr 4, 2024 · Green Cross Lab Cell Corporation (KOSDAQ:A144510) entered into a definitive merger agreement to acquire Green Cross Cell Corporation (KOSDAQ:A031390) from a group of shareholders for approximately KRW 510 billion. CI. Summary: Quotes: Charts: News: Ratings: Calendar: Company: Financials: Consensus: diamond casino heist money
Green Cross Lab Cell Corporation (South Korea) - EMIS
http://www.cnrres.com/en/about-us/company-info/ WebOct 30, 2024 · GCCL will serve as a central laboratory that analyzes biosamples (human biologicals such as blood, urine, etc.) from throughout clinical trial phases 1-4. A central laboratory is a type of institute in which samples from before and after clinical trials are examined and tested. WebGreen Cross Lab Cell and C&R Research Signs Joint Investment Agreement to Establish “GCCL” C&R Research Clinical Trial Symposium to Mark 22nd Anniversary Ends in Success; Why C&R Research is seeking U.S. CRO acquisition and KOSDAQ IPO; C&R Research and LegoChem Biosciences Sign Joint R&D of Next Generation Antibiotics circrna analysis pipeline